GE HealthCare’s SIGNA MRI Portfolio Granted FDA Clearance

GE HealthCare’s SIGNA MRI Portfolio Granted FDA Clearance

Feb. 19, 2026 — GE HealthCare recently announced 510(k) clearance of three new magnetic resonance (MR) innovations…

Continue Reading
GE HealthCare wins FDA clearance for Allia Moveo interventional imaging system

GE HealthCare wins FDA clearance for Allia Moveo interventional imaging system

GE HealthCare has received U.S. Food and Drug Administration 510(k) clearance and CE Marking for Allia…

Continue Reading
GE Healthcare’s Allia Moveo Platform Receives FDA Clearance, CE Mark

GE Healthcare’s Allia Moveo Platform Receives FDA Clearance, CE Mark

Feb. 2, 2026 — GE HealthCare has announced that Allia Moveo has received U.S. Food and Drug…

Continue Reading
GE HealthCare secures FDA clearance and CE mark for deep learning tech

GE HealthCare secures FDA clearance and CE mark for deep learning tech

GE HealthCare announced the FDA submission at the Radiological Society of North America’s (RSNA) 2024 meeting…

Continue Reading
GE HealthCare Receives FDA Clearance for Aurora and Clarify DL

GE HealthCare Receives FDA Clearance for Aurora and Clarify DL

May 5, 2025 — GE HealthCare recently announced that the U.S. Food and Drug Administration (FDA)…

Continue Reading
GE Healthcare wins FDA clearance for Alzheimer’s imaging software

GE Healthcare wins FDA clearance for Alzheimer’s imaging software

Dive Brief: GE Healthcare has received 510(k) clearance for a tool designed to help clinicians assess…

Continue Reading